Table 1.

Serum C2C means standard deviation at different study times and treatment groups.

Study time	CT	PRGF	AMSCs	PRGF + AMSCs
Baseline	19.80 ± 2.46	21.59 ± 3.70	20.27 ± 4.70	19.66 ± 2.54
28 days post-infiltration	63.94 ± 3.92	59.16 ± 3.65	58.15 ± 3.31	44.43 ± 2.98
56 days post-infiltration	51.75 ± 3.44	40.34 ± 3.36	41.29 ± 3.50	30.61 ± 2.94
84 days post-infiltration	44.89 ± 2.94	31.54 ± 2.84	31.20 ± 4.02	18.66 ± 3.17

CT, control; PRGF, plasma rich in growth factors; AMSCs, adipose mesenchymal stromal cells; PRGF + AMSCs, combination of plasma rich growth factors with adipose mesenchymal stromal cells.